In conclusion, our findings revealed that the hepatic PANX1–IL‐33 axis protects against endotoxemia and liver injury by targeting ST2+ Tregs and promoting the early resolution of hyperinflammation. This evidence concerns the gene IL1RL1 and serum lipopolysaccharide activity.